HONG KONG – Regulators in India have approved phase II trials for the protein drug that targets blood clots and could help treat heart attack patients with fewer risks and side effects than existing treatments. It may be the first biopharmaceutical compound fully developed in the country.
SHANGHAI – Xin Chun Kuai Le! Kung Hei Fat Choi! The first is Mandarin for “Happy Spring Festival.” The second is the Cantonese equivalent of “Wishing you prosperity.”
HONG KONG – After a lost 2013, companies in China are expected to start issuing shares again this year and this could prove a boon to biopharmaceutical companies that are generally underrepresented in the markets in Shanghai and Shenzhen.
